Clinical Trial Update: A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3, multi-center study evaluating three doses of meloxicam versus placebo in patients with rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• MELOXICAM (MELOXICAM)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: COMPLETED